Projects per year
Personal profile
Personal profile
Dr. Hanh Mai is triple board-certified in oncology, hematology, and internal medicine. She has a special interest in treating Breast Cancer, benign and malignant heme disorders.
Her other professional interests include participation in the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physician, the American Medical Association, and the American Osteopathic Association.
Dr. Mai previously practiced medicine at Loyola University Medical Center, Edward J. Hines VA, Jr. Hospital, and was recently promoted as an associate professor Loyola University Chicago Stritch School of Medicine.
Dr. Mai received her Bachelor of Science and Master of Medical Sciences from Loyola University Chicago and her Doctorate Osteopathic Medicine from Des Moines University-COM. Additionally, she completed her residency and fellowship in hematology/oncology at Loyola University Medical Center.
Research Area Keywords
- Clinical Care
- Cancer
Fingerprint
Dive into the research topics where Hanh P. Mai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma
Ganguly, S. (PI), Heslop, H. (Key Personnel), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
1/28/25 → …
Project: Clinical Trial
-
A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants With Acute Leukemia
Shah, S. (PI), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Mai, H. P. (Key Personnel) & Pingali, S. R. (Key Personnel)
10/25/24 → …
Project: Clinical Trial
-
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Shah, S. (Key Personnel) & Yi, Q. (Key Personnel)
7/29/24 → …
Project: Clinical Trial
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abdelrahim, M. (Key Personnel), Chang, J. C. (Key Personnel), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Shah, S. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects with Relapsed / Refractory Multiple Myeloma (MM)
Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
3/21/24 → …
Project: Clinical Trial
-
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Burns, E. A., Wilson, J. J., Mathur, S., Kieser, R., Gong, Z., Hu, C. C. A., Tang, C. H. A., Petkova, J., Yuen, C., Mai, H., Shah, S., Rice, L., Ganguly, S. & Pingali, S. R., Oct 2023, In: Annals of Hematology. 102, 10, p. 2753-2763 11 p.Research output: Contribution to journal › Article › peer-review
-
COVID-19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population
Berg, S., Kim, S. H., Wozniak, A., Odetola, O., Arain, S., Aleem, A., Coggan, J., Dave, A., Elliott, E., Guerrettaz, R., Dalal, H., Lee, R., Kodali, A., Moore, P., Patel, S., Rajakumar, P., Qin, S., Delgado Ramos, G., Schwartz, C. & Esmail, F. & 15 others, , Jun 1 2022, In: American Journal of Hematology. 97, 6, p. E217-E220Research output: Contribution to journal › Letter › peer-review
Open Access -
Hodgkin's lymphoma with HLH and complete remission with brentuximab-based therapy
Knox, B., Singh, D., Mai, H. & Mirza, K., Dec 8 2019, In: BMJ Case Reports. 12, 12, e231629.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Genetics of Hypercoagulable and Hypocoagulable States
Singh, D., Natarajan, A., Nand, S. & Mai, H. P., Oct 2018, In: Neurosurgery clinics of North America. 29, 4, p. 493-501 9 p.Research output: Contribution to journal › Review article › peer-review
7 Scopus citations -
Acquired coagulation disorders
Kruczek, K., Cooper, K., Mai, H. & Nand, S., Jun 7 2016, Anticoagulation and Hemostasis in Neurosurgery. Springer International Publishing, p. 115-128 14 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter